I´m not working for the clampdown

The paper states that researchers are trying to make biotechnology open source amid concerns that corporate interests will block their work with patents. The issue of patent-based monopolies in the drugs business became one of the campaigning issues for the Swedish Pirate Party,ostensibly on the back of revulsion at anti-filesharing legislation introduced by the Swedish government. People have outlined alternatives to the current situation, in which, having paid for the research, pharmaceutical companies get to enjoy a monopoly supply situation for 20-odd years, assuming that the resulting treatment actually works. This is the pact that governments of industrialised nations made with inventors more than a century ago: in exchange for revealing trade secrets, inventors are protected from competition for a finite period of time.